Caudill Cortney
SEC CIK 2090209 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | SVP, COO | 16.5K | — | $2.23M | 6 | 2025-11-01 | 2026-03-09 |
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-10 | 2026-03-09+ | HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, COO | S - Sale+OE | $67.75 | -28.9K | 16.5K | -64% | -$1.96M |
| DM | 2026-03-10 | 2026-03-09+ | HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, COO | M - OptEx | $33.51 | +21.5K | 34.4K | +168% | +$722.0K |
| D | 2026-02-24 | 2026-02-20 | HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, COO | M - OptEx | $0.00 | +2,666 | 15.4K | +21% | $0 |
| D | 2026-02-24 | 2026-02-20 | HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, COO | F - Tax | $70.98 | -1,037 | 14.4K | -7% | -$73.6K |
| D | 2025-12-19 | 2025-11-01 | HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, COO | M - OptEx | $0.00 | +9,326 | 17.0K | +122% | $0 |
| D | 2025-12-19 | 2025-11-01 | HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, COO | S - Sale+OE | $65.19 | -4,263 | 12.7K | -25% | -$277.9K |
Purchase Sale Sale after option exercise All abbreviations